SCHEMBL17058026

SCHEMBL17058026

C#[SH](Cc1ccc(NC=C=N)cc1)N1CCN(c2cnn(-c3cc(F)cc(F)c3)c(=O)c2OCC2(C)CC2)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17058032 0.85 — —
SCHEMBL17058015 0.74 SLC2A1 (0.35) —
SCHEMBL17058382 0.74 SLC2A1 (0.35) —
SCHEMBL17058202 0.74 SLC2A1 (0.36) —
SCHEMBL17058351 0.73 CA12 (0.35) —
SCHEMBL17058575 0.73 SLC2A1 (0.30) —
SCHEMBL17058467 0.73 NPSR1 (0.33) —
SCHEMBL17058345 0.73 RAB9A (0.34) —
SCHEMBL14899899 0.73 USP2 (0.35) —
SCHEMBL11945379 0.72 NPSR1 (0.39) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137179-B1 PYRIDAZINONE DERIVATIVES USEFUL AS GLUCAN SYNTHASE INHIBITORS MERCK SHARP & DOHME (US) 2015-09-02 — — EP disclosed
Send feedback